Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apidra Glulisine Safety and Effectiveness in Type 1 Diabetes
NCT00489190Phase 4Completed
- Sponsor
- Sanofi
- Start
- Aug 2005
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of insulin glulisine in type 1 diabetes mellitus (T1D), sponsored by Sanofi. Started Aug 2005; status: completed.
02
Drugs
insulin glulisine
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00489190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00489190.